 |
|
dactinomycin
A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus. Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | ACT-D
Actinomycin A IV
actinomycin C1
actinomycin D
Actinomycin I1
Actinomycin IV
Actinomycin X 1
Actinomycin-[thr-val-pro-sar-meval]
AD
Dactinomycine
Meractinomycin | | | | US brand names: | | Cosmegen
Lyovac Cosmegen | | | | Abbreviation: | | DACT | | | | Chemical structure name: | | 2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3 | | |
|
|
